Today: 15 June 2026
D-Wave Heads Into $100 Million U.S. Challenge as Quantum Peer Stocks Jump
26 May 2026
2 mins read

D-Wave Heads Into $100 Million U.S. Challenge as Quantum Peer Stocks Jump

New York, May 26, 2026, 06:01 EDT

  • D-Wave quoted at $29.28 premarket, down 0.4%. Shares finished Friday up 14.2% at $29.40.
  • The stock jumped roughly 44.5% last week after investors picked up on a proposed $100 million CHIPS Act funding agreement.
  • U.S. funding hasn’t closed yet, and the share sale plan would hand the government an equity stake.

D-Wave Quantum Inc. shares edged lower before the bell Tuesday. The move follows a strong rally after the latest funding round, which saw the stock jump about 44.5% last week. The shares, traded in New York, were at $29.28 as of 5:56 a.m. EDT, off 0.4%. They closed Friday at $29.40, up 14.2% that day. StockAnalysis

U.S. markets reopened following the Memorial Day holiday, and traders are weighing if the latest jump in quantum-computing stocks will keep going. NYSE recognizes May 25 as the Memorial Day holiday for markets in 2026, according to its calendar. Reuters said S&P 500 and Nasdaq futures were higher early Tuesday as trading resumed after the break. NYSE

D-Wave is moving on a letter of intent with the U.S. Department of Commerce to secure $100 million in potential CHIPS and Science Act funding. The company said the funds would go to scaling its annealing and gate-model quantum systems. In exchange, D-Wave would issue $100 million worth of common stock to the department if the deal is finalized. Business Wire

Stocks are moving on federal spending news. Last week, Reuters said the Biden administration is planning to take $2 billion in equity stakes in nine quantum-computing firms. IBM could get $1 billion, GlobalFoundries $375 million, and D-Wave, Rigetti Computing and Infleqtion are each in line for about $100 million. Reuters

Quantum computing taps quantum physics to handle tough problems that traditional computers can find hard. D-Wave is known for quantum annealing—mainly used in optimization tasks like scheduling, routing, or resource allocation. The company is also at work on gate-model systems, which rivals including IBM and Rigetti are building.

D-Wave CEO Alan Baratz said the planned U.S. investment would “scale quantum innovation domestically,” and could help speed up both fabrication and customer applications. Baratz’s statement came in the company’s funding release. Business Wire

D-Wave gave investors an update on operating numbers ahead of the funding deal. First-quarter revenue came in at $2.9 million, down 81% from last year. Bookings jumped to $33.4 million from $1.6 million. Bookings represent future revenue from customer orders. The period’s numbers also reflect a $20 million system sale to Florida Atlantic University and a $10 million two-year quantum-computing-as-a-service contract with a Fortune 100 company. Business Wire

Bulls point to the balance sheet. D-Wave closed March holding $588.4 million in cash and marketable securities, almost double what it had a year ago. Remaining performance obligations jumped to $42.4 million. Business Wire

Risks are clear. The funding still needs final documents, and D-Wave’s SEC filing said talks might stop or be called off, targets might slip, funds might fall through, and current shareholders could see dilution from the new stock. The company reported a first-quarter net loss of $18.4 million. That’s up from a $5.4 million loss last year. SEC

Competition is moving. IBM plans to use its award on a quantum-chip manufacturing venture, and GlobalFoundries said it is adding quantum technology manufacturing capacity. Rigetti and Infleqtion are also among those getting funds. The group draws attention to whether Washington is putting money behind a range of technical ideas, not just backing a single winner. Reuters

Infleqtion CEO Matthew Kinsella told Reuters the investments “further validate” the idea that quantum computing is moving quicker than a lot of people think. That’s one reason for the sector move, but it means D-Wave will need to show it can turn government support and customer bookings into smoother revenue. Reuters

D-Wave’s first investor day is set for June 1 at the New York Stock Exchange. In the announcement, Baratz said “proof, not potential, will define the winners.” The stock trades above just research fundamentals now. Business Wire

Stock Market Today

  • Jazz Pharmaceuticals Shares Fall 2% After Zepzelca Lung Cancer Study Misses Primary Endpoint
    June 15, 2026, 1:53 PM EDT. Shares of Jazz Pharmaceuticals fell 2.4% after its phase III LAGOON study showed lung cancer drug Zepzelca (lurbinectedin) failed the primary endpoint of overall survival in relapsed small cell lung cancer patients. Median survival was 8.7 months for Zepzelca monotherapy and 10.9 months for combination therapy versus 10.7 months in controls, showing no meaningful benefit. The study was critical for converting accelerated approval granted in 2020 to full approval. Jazz plans to discuss results with the FDA but expects no impact on its 2026 financial outlook. Strong growth in first-line maintenance use of Zepzelca, approved in combination with Tecentriq, helped Jazz post $101 million in first-quarter 2026 sales, up 60% year-over-year.

Latest articles

Pattern Group Slides as Knox Lane Affiliate Plans 8 Million Share Sale

Pattern Group Slides as Knox Lane Affiliate Plans 8 Million Share Sale

15 June 2026
Pattern Group shares plunged 11% to $18.61 after a Knox Lane-affiliated pre-IPO holder launched a secondary offering of 8 million Series A shares, with an option for 1.2 million more; Pattern will not receive proceeds, and the increased share supply weighed on investor sentiment.
Nasdaq Tech Stocks Climb, QQQ Gains After U.S.-Iran Deal Hopes

Nasdaq Tech Stocks Climb, QQQ Gains After U.S.-Iran Deal Hopes

15 June 2026
Invesco QQQ Trust surged 3.1% to $743.54 as a preliminary U.S.-Iran deal sent oil prices down 5%, easing inflation and rate-hike fears, and fueling a tech-led rally with chip stocks like Micron up 9.2% and Nvidia up 3%, while leveraged fund TQQQ soared 9.2%.
Accenture drops on Morgan Stanley downgrade tied to AI spending

Accenture drops on Morgan Stanley downgrade tied to AI spending

15 June 2026
Morgan Stanley downgraded Accenture to Equal Weight and slashed its price target to $177 from $240, citing weaker-than-expected IT services budget growth and AI spending pressure; Accenture shares recently traded near $169, down about 0.8%, after falling 43.9% over the past year as investors await clarity on AI-driven demand ahead of the June 18 earnings call.
Rigetti Computing Stock Jumps Before RGTI Earnings as Quantum Revenue Test Hits Tonight
Previous Story

Rigetti Stock’s $100 Million Quantum Deal Has One Big Catch Traders Can’t Ignore

ServiceNow AI move puts pressure on Salesforce
Next Story

ServiceNow Stock Draws Large Institutional Interest, Latest Filings Suggest Change

Go toTop